2691
One previous study of four transplant patients whose immediate post-transplantation immunosuppression utilized corticosteroids, cyclosporine, MMF, and anti-T-lymphocyte globulin noted anemia in 13% of them.
 four transplant patients: Subject; four: Subject.Population; transplant: Subject.Disorder; anemia: Effect; immediate post-transplantation immunosuppression utilized corticosteroids, cyclosporine, MMF, and anti-T-lymphocyte globulin: Treatment; corticosteroids: Treatment.Drug; cyclosporine: Treatment.Drug; MMF: Treatment.Drug; anti-T-lymphocyte globulin: Treatment.Drug; post-transplantation immunosuppression: Treatment.Disorder; corticosteroids: Combination.Drug; cyclosporine: Combination.Drug; MMF: Combination.Drug; anti-T-lymphocyte globulin: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 four transplant patients: Subject; four: Subject.Population; transplant: Subject.Disorder; anemia: Effect; immediate post-transplantation immunosuppression utilized corticosteroids, cyclosporine, MMF, and anti-T-lymphocyte globulin: Treatment; corticosteroids: Treatment.Drug; cyclosporine: Treatment.Drug; MMF: Treatment.Drug; anti-T-lymphocyte globulin: Treatment.Drug; post-transplantation immunosuppression: Treatment.Disorder; corticosteroids: Combination.Drug; cyclosporine: Combination.Drug; MMF: Combination.Drug; anti-T-lymphocyte globulin: Combination.Drug